Cargando…
Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda
Preventive chemotherapy with single-dose praziquantel is the WHO-recommended intervention strategy to eliminate schistosomiasis as a public health problem in endemic countries. Surveillance of drugs used in mass drug administration (MDA) programs is recommended to evaluate its effectiveness in reduc...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536561/ https://www.ncbi.nlm.nih.gov/pubmed/37764978 http://dx.doi.org/10.3390/pathogens12091170 |
_version_ | 1785112896719552512 |
---|---|
author | Kabatende, Joseph Ntirenganya, Lazare Mugisha, Michael Barry, Abbie Ruberanziza, Eugene Bienvenu, Emile Bergman, Ulf Aklillu, Eleni |
author_facet | Kabatende, Joseph Ntirenganya, Lazare Mugisha, Michael Barry, Abbie Ruberanziza, Eugene Bienvenu, Emile Bergman, Ulf Aklillu, Eleni |
author_sort | Kabatende, Joseph |
collection | PubMed |
description | Preventive chemotherapy with single-dose praziquantel is the WHO-recommended intervention strategy to eliminate schistosomiasis as a public health problem in endemic countries. Surveillance of drugs used in mass drug administration (MDA) programs is recommended to evaluate its effectiveness in reducing transmissions. After a decade-long implementation of a school-based MDA program in Rwanda, we conducted efficacy surveillance of single-dose praziquantel MDA against S. mansoni infection. Two weeks before MDA, stool examinations were performed to screen MDA-eligible school children (n = 4998) for S. mansoni infection using the Kato–Katz technique, and 265 (6.5%) children tested positive for the infection. All children received praziquantel and albendazole as preventive chemotherapy through the MDA campaign. Infected children were enrolled and followed for efficacy monitoring, and stool examination was repeated after three weeks post-MDA (n = 188). Before treatment, 173 (92%) had a light infection, and 15 (8%) had a moderate infection intensity. The primary and secondary outcomes were parasitological cure and egg reduction rates at three weeks post-treatment. The overall cure and egg reduction rates for S. mansoni infection were 97.9% (95% CI = 94.6–99.4) and 97.02%, respectively. Among the 173 children with light infection intensity, 170 (98.3%, 95% CI = 95.0–99.6) were cured, and among the 15 children who had moderate infection intensity, 14 (93.3%) were cured. No significant association between cure rate and pre-treatment infection intensity was observed. We conclude that single-dose praziquantel is efficacious against light-to-moderate S. mansoni infection. Preventive chemotherapy with praziquantel effectively reduces schistosome reservoirs and transmission among school-age children. |
format | Online Article Text |
id | pubmed-10536561 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-105365612023-09-29 Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda Kabatende, Joseph Ntirenganya, Lazare Mugisha, Michael Barry, Abbie Ruberanziza, Eugene Bienvenu, Emile Bergman, Ulf Aklillu, Eleni Pathogens Article Preventive chemotherapy with single-dose praziquantel is the WHO-recommended intervention strategy to eliminate schistosomiasis as a public health problem in endemic countries. Surveillance of drugs used in mass drug administration (MDA) programs is recommended to evaluate its effectiveness in reducing transmissions. After a decade-long implementation of a school-based MDA program in Rwanda, we conducted efficacy surveillance of single-dose praziquantel MDA against S. mansoni infection. Two weeks before MDA, stool examinations were performed to screen MDA-eligible school children (n = 4998) for S. mansoni infection using the Kato–Katz technique, and 265 (6.5%) children tested positive for the infection. All children received praziquantel and albendazole as preventive chemotherapy through the MDA campaign. Infected children were enrolled and followed for efficacy monitoring, and stool examination was repeated after three weeks post-MDA (n = 188). Before treatment, 173 (92%) had a light infection, and 15 (8%) had a moderate infection intensity. The primary and secondary outcomes were parasitological cure and egg reduction rates at three weeks post-treatment. The overall cure and egg reduction rates for S. mansoni infection were 97.9% (95% CI = 94.6–99.4) and 97.02%, respectively. Among the 173 children with light infection intensity, 170 (98.3%, 95% CI = 95.0–99.6) were cured, and among the 15 children who had moderate infection intensity, 14 (93.3%) were cured. No significant association between cure rate and pre-treatment infection intensity was observed. We conclude that single-dose praziquantel is efficacious against light-to-moderate S. mansoni infection. Preventive chemotherapy with praziquantel effectively reduces schistosome reservoirs and transmission among school-age children. MDPI 2023-09-17 /pmc/articles/PMC10536561/ /pubmed/37764978 http://dx.doi.org/10.3390/pathogens12091170 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Kabatende, Joseph Ntirenganya, Lazare Mugisha, Michael Barry, Abbie Ruberanziza, Eugene Bienvenu, Emile Bergman, Ulf Aklillu, Eleni Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
title | Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
title_full | Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
title_fullStr | Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
title_full_unstemmed | Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
title_short | Efficacy of Single-Dose Praziquantel for the Treatment of Schistosoma mansoni Infections among School Children in Rwanda |
title_sort | efficacy of single-dose praziquantel for the treatment of schistosoma mansoni infections among school children in rwanda |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10536561/ https://www.ncbi.nlm.nih.gov/pubmed/37764978 http://dx.doi.org/10.3390/pathogens12091170 |
work_keys_str_mv | AT kabatendejoseph efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT ntirenganyalazare efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT mugishamichael efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT barryabbie efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT ruberanzizaeugene efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT bienvenuemile efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT bergmanulf efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda AT aklillueleni efficacyofsingledosepraziquantelforthetreatmentofschistosomamansoniinfectionsamongschoolchildreninrwanda |